These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 8930573

  • 1. The changing role of H2-receptor antagonists in acid-related diseases.
    Lamers CB.
    Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S3-7. PubMed ID: 8930573
    [Abstract] [Full Text] [Related]

  • 2. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    Bardou M.
    Rev Prat; 2001 Apr 15; 51(7):789-95. PubMed ID: 11387678
    [No Abstract] [Full Text] [Related]

  • 3. Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine.
    Adamek RJ, Behrendt J, Wenzel C.
    Eur J Gastroenterol Hepatol; 2001 Jul 15; 13(7):811-7. PubMed ID: 11474311
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG, Berstad A.
    Clin Pharmacokinet; 1996 Nov 15; 31(5):386-406. PubMed ID: 9118586
    [Abstract] [Full Text] [Related]

  • 5. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D, Paré P, Pericak D, Pyzyk M, Canadian Pantoprazole GERD Study Group.
    Am J Gastroenterol; 2001 Oct 15; 96(10):2849-57. PubMed ID: 11695354
    [Abstract] [Full Text] [Related]

  • 6. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
    Gallo S, Dibildox M, Moguel A, Di Silvio M, Rodríguez F, Almaguer I, García C.
    Rev Gastroenterol Mex; 1998 Oct 15; 63(1):11-6. PubMed ID: 10068743
    [Abstract] [Full Text] [Related]

  • 7. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
    Holtmann G, Layer P, Goebell H.
    Z Gastroenterol; 1996 May 15; 34(5):267-72. PubMed ID: 8686357
    [Abstract] [Full Text] [Related]

  • 8. Pantoprazole, Prout and the proton pump.
    Playford RJ, Podas T, Modlin I.
    Hosp Med; 1999 Jul 15; 60(7):500-4. PubMed ID: 10605542
    [Abstract] [Full Text] [Related]

  • 9. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ, Hunt RH.
    Yale J Biol Med; 1999 Jul 15; 72(2-3):181-94. PubMed ID: 10780580
    [Abstract] [Full Text] [Related]

  • 10. [Pantoprazole. A new acid pump inhibitor against peptic ulcer and reflux esophagitis].
    Wilson BV, Knudsen T.
    Ugeskr Laeger; 1996 Mar 18; 158(12):1695-7. PubMed ID: 8644421
    [No Abstract] [Full Text] [Related]

  • 11. Drug therapy of peptic ulcer disease.
    Ching CK, Lam SK.
    Br J Hosp Med; 1996 Mar 18; 54(2-3):101-6. PubMed ID: 7551483
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
    van Zyl JH, de K Grundling H, van Rensburg CJ, Retief FJ, O'Keefe SJ, Theron I, Fischer R, Bethke T.
    Eur J Gastroenterol Hepatol; 2000 Feb 18; 12(2):197-202. PubMed ID: 10741935
    [Abstract] [Full Text] [Related]

  • 13. Eradication of Helicobacter pylori does not decrease the long-term use of acid-suppressive medication.
    Tan AC, Hartog GD, Mulder CJ.
    Aliment Pharmacol Ther; 1999 Nov 18; 13(11):1519-22. PubMed ID: 10571610
    [Abstract] [Full Text] [Related]

  • 14. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
    Cheer SM, Prakash A, Faulds D, Lamb HM.
    Drugs; 2003 Nov 18; 63(1):101-33. PubMed ID: 12487624
    [Abstract] [Full Text] [Related]

  • 15. Treatment of reflux oesophagitis of moderate and severe grade with ranitidine or pantoprazole--comparison of 24-hour intragastric and oesophageal pH.
    Armbrecht U, Abucar A, Hameeteman W, Schneider A, Stockbrügger RW.
    Aliment Pharmacol Ther; 1997 Oct 18; 11(5):959-65. PubMed ID: 9354207
    [Abstract] [Full Text] [Related]

  • 16. [Proton pump inhibitors in pediatrics].
    Faure C, Pelatan C, Languepin J.
    Arch Pediatr; 1999 Jun 18; 6(6):650-6. PubMed ID: 10394458
    [Abstract] [Full Text] [Related]

  • 17. Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication.
    Graham DY, Hammoud F, El-Zimaity HM, Kim JG, Osato MS, El-Serag HB.
    Aliment Pharmacol Ther; 2003 May 15; 17(10):1229-36. PubMed ID: 12755836
    [Abstract] [Full Text] [Related]

  • 18. Pantoprazole--a third proton pump inhibitor.
    Drug Ther Bull; 1997 Dec 15; 35(12):93-4. PubMed ID: 9614720
    [No Abstract] [Full Text] [Related]

  • 19. Triple therapy as a cure for Helicobacter pylori infection.
    Bardhan KD.
    Eur J Gastroenterol Hepatol; 1996 Oct 15; 8 Suppl 1():S27-30. PubMed ID: 8930577
    [Abstract] [Full Text] [Related]

  • 20. Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicenter study.
    Koop H, Schepp W, Dammann HG, Schneider A, Lühmann R, Classen M.
    J Clin Gastroenterol; 1995 Apr 15; 20(3):192-5. PubMed ID: 7797824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.